Orthopedic company Corin Group ("Corin"), backed by the Permira funds, has acquired the US-based OMNI Orthopedics ("OMNI"), a pioneer in robotic-assisted total knee replacement. It is further evidence of Permira and their co-investors' determination to accelerate Corin's strong organic growth with a focused M&A strategy.

Founded in 1999 by a team of medical device engineers, OMNI is now at the forefront of robotic-assisted knee replacement. Their OMNIBotics^® is a unique imageless total knee replacement solution which combines a robotic cutting guide with the world's first robotic tool to measure ligament function. The system allows tailoring of the implant positioning to each individual patient, resulting in less patient pain and faster rehabilitation.  

Corin's strategy is to revolutionize orthopedics by gaining, understanding and sharing insight at every stage of the joint replacement experience and delivering  clinically proven implants which are optimized by unique procedural technologies. OMNIBotics^®, combined with APEX knee replacement, accelerates Corin's strategy.  

Corin is creating a connected digital ecosystem that combines biomechanical, physiological and logistical information to generate insight; this ecosystem will empower patients throughout their treatment journey and support surgeons to improve patient outcomes and maximize value for the healthcare system. This is Connected Orthopaedic Insight.